Cargando…

Response to Treatment with Recombinant Human Growth Hormone (rhGH) of Short Stature Children Born Too Small for Gestational Age (SGA) in Selected Centres in Poland

Short stature resulting from SGA is an obligatory indication for treatment with rhGH. The aim of the study was to assess the response to rhGH treatment in patients treated in the years 2016–2020 in six clinical centers in Poland. During the analysis, auxological data were collected, and anthropometr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glińska, Marta, Walczak, Mieczysław, Wikiera, Beata, Pyrżak, Beata, Majcher, Anna, Paluchowska, Monika, Gawlik, Aneta, Antosz, Aleksandra, Kusz, Marcin, Bossowski, Artur, Stożek, Karolina, Wędrychowicz, Anna, Starzyk, Jerzy, Petriczko, Elżbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181578/ https://www.ncbi.nlm.nih.gov/pubmed/35683483 http://dx.doi.org/10.3390/jcm11113096

Ejemplares similares

Difficulties in Interpreting IGF-1 Levels in Short Stature Children Born Small for Gestational Age (SGA) Treated with Recombinant Human Growth Hormone (rhGH) Based on Data from Six Clinical Centers in Poland
por: Glińska, Marta, et al.
Publicado: (2023)

Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2021)

GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy
por: Savage, Martin O., et al.
Publicado: (2021)

Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH
por: Chen, Hong, et al.
Publicado: (2023)

Corrigendum: Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Silver-Russell syndrome and Turner syndrome in a girl with short stature treated with growth hormone – case report
por: Wikiera, Beata, et al.
Publicado: (2022)

Noonan syndrome: rhGH treatment and PTPN11 mutation
por: Wu, Xian, et al.
Publicado: (2023)

GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism
por: Tauber, M, et al.
Publicado: (2007)

GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature
por: Apel, Anja, et al.
Publicado: (2022)

SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)
por: Schwarz, Hans-Peter, et al.
Publicado: (2019)

Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: Li, Juan, et al.
Publicado: (2021)

Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD
por: Blum, Werner F, et al.
Publicado: (2021)

Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature
por: Apel, Anja, et al.
Publicado: (2022)

Retracted: Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance
por: Cianfarani, Stefano
Publicado: (2021)

Inside the Noonan “universe”: Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns
por: Stagi, Stefano, et al.
Publicado: (2022)

Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
por: Felício, João Soares, et al.
Publicado: (2019)

The pre-treatment characteristics and evaluation of the effects of recombinant human growth hormone therapy in children with growth hormone deficiency and celiac disease or inflammatory bowel disease
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2018)

PSAT108 Impact of recombinant human growth hormone (rhGH) on skeletal muscle strength, power, endurance and agility in prepubertal boys with significant short stature: preliminary results
por: Welch, Lurah, et al.
Publicado: (2022)

SAT-096 Response to RHGH Therapy in Children with Isolated Short Stature with or Without an Identified Genetic Cause
por: De Andrade, Nathalia Liberatoscioli Menezes, et al.
Publicado: (2020)

Ten years with biosimilar rhGH in clinical practice in Sweden – experience from the prospective PATRO children and adult studies
por: Lundberg, Elena, et al.
Publicado: (2020)

Predicted health care profile after transition to adult care in Turner syndrome children—experience of single center
por: Witkowska-Krawczak, Ewa, et al.
Publicado: (2023)

Development of obesity from childhood to adolescents
por: Majcher, Anna, et al.
Publicado: (2021)

The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty
por: Wang, Mengjie, et al.
Publicado: (2016)

The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review
por: Chen, Meiping, et al.
Publicado: (2021)

Increase of jump performance during GH treatment in short children born SGA
por: Schweizer, Roland, et al.
Publicado: (2023)

Changes of Peripheral Th17 Cells Subset in Overweight and Obese Children After Body Weight Reduction
por: Artemniak-Wojtowicz, Dorota, et al.
Publicado: (2022)

The incidence and causes of acute hospitalizations and emergency room visits in adolescents with type 1 diabetes mellitus prior to and during the COVID-19 pandemic: a single-centre experience
por: Nowak, Zuzanna, et al.
Publicado: (2022)

Thyroid function in children with growth hormone deficiency during long-term growth hormone replacement therapy
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2018)

Serum TSH level in obese children and its correlations with atherogenic lipid indicators and carotid intima media thickness
por: Rumińska, Małgorzata, et al.
Publicado: (2018)

Stratifying the Genetic Aetiology in Children Born Small for Gestational Age With Persistent Short Stature (SGA-SS)
por: Toni, Ledjona, et al.
Publicado: (2021)

SUN-250 Natural History of Growth in Patients with SHOX Gene Haploinsufficiency and Impact of Treatment with rhGH in Adult Height
por: Menezes De Andrade, Nathalia, et al.
Publicado: (2019)

Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study
por: Soliman, Ashraf T, et al.
Publicado: (2019)

Vitamin D Effects on Selected Anti-Inflammatory and Pro-Inflammatory Markers of Obesity-Related Chronic Inflammation
por: Krajewska, Maria, et al.
Publicado: (2022)

Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls
por: Slattery, Meghan, et al.
Publicado: (2014)

mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)
por: Ghasemi, Rohollah, et al.
Publicado: (2018)

Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation
por: Tornese, Gianluca, et al.
Publicado: (2019)

Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
por: Erazmus, Michał, et al.
Publicado: (2022)

Growth Outcome and Metabolic Profile of PWS Patients Treated With GH and Differences Between AGA and SGA Group
por: Yoon, Ju Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4034bessvk6a470gl3fn7o6s3j